公开(公告)号：US06591313B1

公开(公告)日：2003-07-08

申请号：US09583810

申请日：2000-05-30

申请人： Hajime Hata ,  Junji Kato ,  Makoto Sato

发明人： Hajime Hata ,  Junji Kato ,  Makoto Sato

IPC分类号： G06F1314

CPC分类号： H04L12/40065 ,  H04L12/64 ,  H04N5/4401 ,  H04N5/775 ,  H04N5/782 ,  H04N9/8042 ,  H04N21/43632

摘要： It becomes possible for a user to set a transmission or reception channel arbitrarily and easily, by having each piece of equipment connected to an IEEE 1394 bus include a register provided within a RAM 113 to thereby set a transmission or reception default channel. If channels used in the transmission and the reception are not set when the transmission is started, then the default channel may be used. When equipment is set to a channel setting mode by operating an operation section 116, a control section 112 may display a channel setting picture on a display section 115. In this state, a user may select a set channel by operating an up-key 116a and a down-key 116b of the operation section 116. Thereafter, when a user operates a “YES” key 116c, the control section 112 may write a selected channel in the above-mentioned register, and ends a default channel setting operation. A user can set the transmission or reception channel arbitrarily and easily.

摘要翻译： 用户可以通过使连接到IEEE 1394总线的每个设备包括RAM 113中提供的寄存器来任意和容易地设置发送或接收信道，从而设置发送或接收默认信道。 如果发送和接收中使用的信道在发送开始时未设置，则可以使用默认信道。 当通过操作操作部分116将设备设置为通道设置模式时，控制部分112可以在显示部分115上显示频道设置画面。在该状态下，用户可以通过操作上键116a来选择设定的频道 和操作部分116的下划线116b。此后，当用户操作“是”键116c时，控制部分112可以将所选择的频道写入上述寄存器中，并结束默认频道设置操作。 用户可以任意且容易地设置发送或接收通道。

公开(公告)号：US20070174510A1

公开(公告)日：2007-07-26

申请号：US11710343

申请日：2007-02-23

申请人： Hajime Hata ,  Junji Kato ,  Makoto Sato

发明人： Hajime Hata ,  Junji Kato ,  Makoto Sato

IPC分类号： G06F13/00

CPC分类号： H04L12/40065 ,  H04L12/64 ,  H04N5/4401 ,  H04N5/775 ,  H04N5/782 ,  H04N9/8042 ,  H04N21/43632

摘要： It becomes possible for a user to set a transmission or reception channel arbitrarily and easily. Each of equipment connected to an IEEE 1394 bus may include a register provided within a RAM 113 to thereby set a transmission or reception default channel. If channels used in the transmission and the reception are not set when the transmission is started, then default channel may be used. When equipment is set to a channel setting mode by operating an operation section 116, a control section 112 may display a channel setting picture on a display section 115. In this state, a user may select a set channel by operating an up-key 116a and a down-key 116b of the operation section 116. Thereafter, when a user operates a “YES” key 116c, the control section 112 may write a selected channel in the above-mentioned register, and ends a default channel setting operation. A user can set the transmission or reception channel arbitrarily and easily.

摘要翻译： 用户可以任意且容易地设置发送或接收信道。 连接到IEEE 1394总线的每个设备可以包括设置在RAM 113内的寄存器，从而设置发送或接收默认信道。 如果发送和接收中使用的信道在发送开始时未设置，则可以使用默认信道。 当通过操作操作部分116将设备设置为通道设置模式时，控制部分112可以在显示部分115上显示频道设置画面。 在这种状态下，用户可以通过操作操作部分116的上键116a和下键116b来选择设定的频道。 此后，当用户操作“是”键116c时，控制部分112可以将所选择的频道写入上述寄存器中，并且结束默认频道设置操作。 用户可以任意且容易地设置发送或接收通道。

公开(公告)号：US07409480B2

公开(公告)日：2008-08-05

申请号：US10303337

申请日：2002-11-25

申请人： Hajime Hata ,  Junji Kato ,  Makoto Sato

发明人： Hajime Hata ,  Junji Kato ,  Makoto Sato

IPC分类号： H04L12/28 ,  H04J3/16 ,  H04J3/02 ,  G06F3/00 ,  G06F13/36

CPC分类号： H04L12/40065 ,  H04L12/64 ,  H04N5/4401 ,  H04N5/775 ,  H04N5/782 ,  H04N9/8042 ,  H04N21/43632

摘要： It becomes possible for a user to set a transmission or reception channel arbitrarily and easily. Each of equipment connected to an IEEE 1394 bus may include a register provided within a RAM 113 to thereby set a transmission or reception default channel. If channels used in the transmission and the reception are not set when the transmission is started, then default channel may be used. When equipment is set to a channel setting mode by operating an operation section 116, a control section 112 may display a channel setting picture on a display section 115. In this state, a user may select a set channel by operating an up-key 116a and a down-key 116b of the operation section 116. Thereafter, when a user operates a “YES” key 116c, the control section 112 may write a selected channel in the above-mentioned register, and ends a default channel setting operation. A user can set the transmission or reception channel arbitrarily and easily.

摘要翻译： 用户可以任意且容易地设置发送或接收信道。 连接到IEEE 1394总线的每个设备可以包括设置在RAM 113内的寄存器，从而设置发送或接收默认信道。 如果发送和接收中使用的信道在发送开始时未设置，则可以使用默认信道。 当通过操作操作部分116将设备设置为通道设置模式时，控制部分112可以在显示部分115上显示频道设置画面。 在这种状态下，用户可以通过操作操作部分116的上键116a和下键116b来选择设定的频道。 此后，当用户操作“是”键116c时，控制部分112可以将所选择的频道写入上述寄存器中，并且结束默认频道设置操作。 用户可以任意且容易地设置发送或接收通道。

公开(公告)号：US07639919B2

公开(公告)日：2009-12-29

申请号：US10268560

申请日：2002-10-10

申请人： Michio Miyano ,  Junji Kato ,  Makoto Sato ,  Yuichi Kageyama ,  Norifumi Kikkawa

发明人： Michio Miyano ,  Junji Kato ,  Makoto Sato ,  Yuichi Kageyama ,  Norifumi Kikkawa

IPC分类号： H04N7/26 ,  H04N5/91

CPC分类号： H04N5/775

摘要： When a signal path in a signal outputting device is changed, the signal outputting device indicates signal path change information representing the change in the signal path to a signal inputting device. Based on the signal path change information, the signal inputting device adaptively changes a signal path between the signal outputting device and the signal inputting device. The signal inputting device can know the signal path in the signal outputting device easier than heretofore, and can simply change the signal path between the signal outputting device and the signal inputting device.

摘要翻译： 当信号输出装置中的信号路径改变时，信号输出装置指示表示到信号输入装置的信号路径变化的信号路径变化信息。 基于信号路径变化信息，信号输入装置自适应地改变信号输出装置和信号输入装置之间的信号路径。 信号输入装置可以比以前更容易地知道信号输出装置中的信号路径，并且可以简单地改变信号输出装置和信号输入装置之间的信号路径。

公开(公告)号：US07372821B2

公开(公告)日：2008-05-13

申请号：US10479675

申请日：2003-04-01

申请人： Makoto Sato ,  Junji Kato ,  Michio Miyano ,  Yuichi Kageyama ,  Norifumi Kikkawa

发明人： Makoto Sato ,  Junji Kato ,  Michio Miyano ,  Yuichi Kageyama ,  Norifumi Kikkawa

IPC分类号： H04N7/00

CPC分类号： H04L12/40117 ,  H04B1/205 ,  H04N5/765 ,  H04N5/775 ,  H04N21/4135 ,  H04N21/43632 ,  H04N21/44227

摘要： The present invention relates to a signal processing system, and proposes the switching operation of device selection which is naturally performed for a user. The signal input device 5 comprises a registration means for registering the signal output devices 3, 4, and an establishment means for, when an establishment request signal requesting the establishment of a signal path is sent from any signal output device 3, 4 out of a plurality of the signal output devices 3, 4, judging whether the signal output device 3, 4, which sent the establishment request signal, is registered in the signal input device 5, and establishing the signal path between the signal output device 3, 4 and the signal input device 5 depending on the judged result, thereby avoiding unnatural operation which is not performed in accordance with user operation, thus making it possible to perform the switching operation of device selection which is naturally performed for a user.

摘要翻译： 信号处理系统技术领域本发明涉及一种信号处理系统，并且提出了对用户自然地执行的设备选择的切换操作。 信号输入装置5包括用于登记信号输出装置3,4的登记装置和用于当从任何信号输出装置3,4发出请求建立信号路径的建立请求信号的建立装置时， 多个信号输出装置3,4判断发送了建立请求信号的信号输出装置3,4是否登录在信号输入装置5中，建立信号输出装置3,4和 信号输入装置5根据判断结果，由此避免根据用户操作而不执行的不自然的操作，从而使得可以执行对用户自然执行的设备选择的切换操作。

公开(公告)号：US09757462B2

公开(公告)日：2017-09-12

申请号：US13885811

申请日：2011-10-20

申请人： Junji Kato ,  Rishu Takimoto

发明人： Junji Kato ,  Rishu Takimoto

IPC分类号： A61K47/26 ,  A61K47/48

CPC分类号： A61K47/26 ,  A61K47/549 ,  A61K47/61 ,  A61K47/6911

摘要： The invention relates to a combined pharmaceutical composition or pharmaceutical preparation, comprising a first component containing a first ligand for a polyspecific lectin in a reticuloendothelial cell and a second component containing a carrier, a labeling agent, or a medicament for treating a disease associated with a target cell, each of which is targeted by a second ligand for a polyspecific lectin in a reticuloendothelial cell different from the first ligand, and also relates to a method for labeling a target cell and a method for treating a disease associated with a target cell, each using the same.

公开(公告)号：US08652526B2

公开(公告)日：2014-02-18

申请号：US13439330

申请日：2012-04-04

申请人： Yoshiro Niitsu ,  Junji Kato ,  Yasushi Sato

发明人： Yoshiro Niitsu ,  Junji Kato ,  Yasushi Sato

IPC分类号： A61K9/127 ,  A61K9/14 ,  A61K31/07 ,  C12N15/11 ,  A61K38/18

CPC分类号： A61K31/07 ,  A61K9/0019 ,  A61K9/127 ,  A61K9/14 ,  A61K31/7088 ,  A61K38/1833 ,  A61K38/1841 ,  A61K38/1858 ,  A61K45/06 ,  A61K47/6911 ,  Y10S514/893 ,  Y10T428/2982 ,  A61K2300/00

摘要： An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.

摘要翻译： 含有类视黄醇衍生物和/或维生素A类似物作为成分的星形胶质细胞特异性药物载体; 一种使用该药物的药物递送方法; 含有该药物的药物; 以及使用该药物的治疗方法。 通过将药物载体与维生素A或维生素A类似物的类视黄醇衍生物结合或将其包封在药物载体中，用于治疗用途的药物可以特异性递送至星形胶质细胞。 结果，可以有效地有效地抑制或预防星形胶质细胞相关疾病，同时尽量减少副作用。 作为抑制星形胶质细胞活性或生长的药物，例如可以将作为胶原特异性分子伴侣的HSP47的siRNA包封在药物载体中。 因此，可以同时抑制I型至IV型胶原的分泌，从而可以有效地抑制纤维化。

公开(公告)号：US20120259492A1

公开(公告)日：2012-10-11

申请号：US13439848

申请日：2012-04-05

申请人： Akihiro YAMAMOTO ,  Junji Kato ,  Yuichi Nakamura ,  Hiroshi Murakami

发明人： Akihiro YAMAMOTO ,  Junji Kato ,  Yuichi Nakamura ,  Hiroshi Murakami

IPC分类号： B60L15/00

CPC分类号： B60K6/52 ,  B60K7/0007 ,  B60K17/02 ,  B60K17/046 ,  B60K17/356 ,  B60K2007/0046 ,  B60K2007/0061 ,  B60K2007/0092 ,  Y02T10/6265 ,  Y10S903/903

摘要： A vehicle includes a first drive device and a second drive device. The first drive device includes a motor, a motor control device, a connection-disconnection device, and a connection-disconnection device controller. When the vehicle is driven in a state where a driving force of the first drive device is substantially zero, or the vehicle is driven only by a driving force of the second drive device, the connection-disconnection device controller couples the connection-disconnection device to establish a connected state of the connection-disconnection device. The motor control device is configured to perform loss reduction control on the motor to reduce at least one of a loss of the motor and a loss in a power transmission path in power transmitted to the first driving wheel, by establishing the connected state of the connection-disconnection device.

摘要翻译： 车辆包括第一驱动装置和第二驱动装置。 第一驱动装置包括电动机，电动机控制装置，连接断开装置和连接断开装置控制器。 当车辆在第一驱动装置的驱动力基本上为零的状态下驱动时，或车辆仅由第二驱动装置的驱动力驱动时，连接断开装置控制器将连接断开装置连接到 建立连接断开装置的连接状态。 电动机控制装置被配置为对电动机执行减少损失控制，以通过建立连接的连接状态来减少电动机的损失和传递到第一驱动轮的动力的动力传递路径的损失中的至少一个 - 连接设备。

公开(公告)号：US20080193512A1

公开(公告)日：2008-08-14

申请号：US11793736

申请日：2005-12-22

申请人： Yoshiro Niitsu ,  Junji Kato ,  Yasushi Sato

发明人： Yoshiro Niitsu ,  Junji Kato ,  Yasushi Sato

IPC分类号： A61K9/127 ,  A61K31/07 ,  A61P35/00

CPC分类号： A61K31/07 ,  A61K9/0019 ,  A61K9/127 ,  A61K9/14 ,  A61K31/7088 ,  A61K38/1833 ,  A61K38/1841 ,  A61K38/1858 ,  A61K45/06 ,  A61K47/6911 ,  Y10S514/893 ,  Y10T428/2982 ,  A61K2300/00

摘要： An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.

摘要翻译： 含有类视黄醇衍生物和/或维生素A类似物作为成分的星形胶质细胞特异性药物载体; 一种使用该药物的药物递送方法; 含有该药物的药物; 以及使用该药物的治疗方法。 通过将药物载体与维生素A或维生素A类似物的类视黄醇衍生物结合或将其包封在药物载体中，用于治疗用途的药物可以特异性递送至星形胶质细胞。 结果，可以有效地有效地抑制或预防星形胶质细胞相关疾病，同时尽量减少副作用。 作为抑制星形胶质细胞活性或生长的药物，例如可以将作为胶原特异性分子伴侣的HSP47的siRNA包封在药物载体中。 因此，可以同时抑制I型至IV型胶原的分泌，从而可以有效地抑制纤维化。

公开(公告)号：US20070192599A1

公开(公告)日：2007-08-16

申请号：US11338669

申请日：2006-01-25

申请人： Junji Kato ,  Hirokazu Tsuruta

发明人： Junji Kato ,  Hirokazu Tsuruta

IPC分类号： H04L9/00

CPC分类号： H04L9/3273 ,  H04L9/0844 ,  H04L9/16 ,  H04L2209/60 ,  H04L2209/805

摘要： After a selection key bundle is determined by a selection key bundle determining process, the following first authentication key authenticating process is executed. An authentication processing part selects a selection encryption key from selection key bundle following a predetermined association based on a received random-number data. On the other hand, another authentication processing part selects an encryption key from the selection key bundle as a selection encryption key, following the association based on the received random-number data, encrypts the random-number data using the selection encryption key so as to acquire encrypted random-number data and transmits to the former authentication processing part. The former authentication processing part decrypts the encrypted random-number data using the selection encryption key so as to acquire decrypted random-number data and then determines whether that authentication is acceptable based on a comparison between the transmission time original random-number data and decrypted random-number data.

摘要翻译： 在通过选择密钥束确定处理确定了选择密钥束之后，执行以下第一认证密钥认证处理。 认证处理部基于接收到的随机数数据，在预定关联之后从选择密钥束中选择选择加密密钥。 另一方面，另一认证处理部从选择密钥包中选择加密密钥作为选择加密密钥，根据接收的随机数数据进行关联，然后使用选择加密密钥加密随机数数据，从而 获取加密的随机数数据并将其发送到前一认证处理部分。 前一认证处理部分使用选择加密密钥对加密的随机数数据进行解密，以便获取解密的随机数数据，然后基于传输时间原始随机数数据和解密随机数之间的比较来确定该认证是否可接受 数字数据。